Fri Nov 14 07:57:26 UTC 2025: Okay, here’s a news article summarizing the provided text, suitable for publication on November 14, 2025:

Headline: Hyderabad’s URAT and Japan’s Teijin Partner to Expand Medical Solutions Across India and Japan

HYDERABAD, INDIA – November 14, 2025 – UR Advanced Therapeutics (URAT), a Hyderabad-based biotechnology firm known for its BioVaram brand, has entered into a strategic agreement with Japanese conglomerate Teijin to jointly develop and market advanced medical technologies in both India and Japan.

The collaboration will focus on leveraging each company’s expertise to address unmet medical needs through innovative therapies. Specifically, the partnership will explore the regulatory approval and commercialization of Teijin Medical Technologies’ Synfolium cardiovascular repair patch in India, as well as expanding the use of Japan Tissue Engineering Co’s regenerative medicine products.

Conversely, Teijin will work with URAT to bring BioVaram technologies to the Japanese market. This includes the commercialization of exosome-based diagnostics and therapeutics, Extracellular Matrix mimics, and bio-derived materials like Type I atelocollagen.

“By combining the expertise of both companies, we are confident in our ability to deliver innovative therapies that address unmet medical needs in both countries,” stated Takayuki Nakano, mission executive and general manager of Teijin’s Regenerative Medicine and Implantable Medical Device Division.

URAT founder and CEO Jaganmohan Reddy emphasized the partnership will strengthen URAT’s capabilities in research, innovation, and scalable manufacturing of advanced tissue engineering products, while enabling Teijin to bring BioVaram’s products to global markets.

The companies will conduct feasibility studies, navigate regulatory pathways, integrate technologies, and assess market needs to advance these initiatives. Plans are also underway for joint product development and manufacturing in cell and gene therapy, including the introduction of Synfolium in India.

The agreement, announced Thursday, marks a significant step towards enhanced healthcare solutions and technological collaboration between India and Japan.

Read More